Applying the RatWalker System for Gait Analysis in a Genetic Rat Model of Parkinson's Disease.


Journal

Journal of visualized experiments : JoVE
ISSN: 1940-087X
Titre abrégé: J Vis Exp
Pays: United States
ID NLM: 101313252

Informations de publication

Date de publication:
18 01 2021
Historique:
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 27 2 2021
Statut: epublish

Résumé

Parkinson's disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic (DA) neurons in the substantia nigra pars compacta. Gait abnormalities, including decreased arm swing, slower walking speed, and shorter steps are common in PD patients and appear early in the course of disease. Thus, the quantification of motor patterns in animal models of PD will be important for phenotypic characterization during disease course and upon therapeutic treatment. Most cases of PD are idiopathic; however, the identification of hereditary forms of PD uncovered gene mutations and variants, such as loss-of-function mutations in Pink1 and Parkin, two proteins involved in mitochondrial quality control that could be harnessed to create animal models. While mice are resistant to neurodegeneration upon loss of Pink1 and Parkin (single and combined deletion), in rats, Pink1 but not Parkin deficiency leads to nigral DA neuron loss and motor impairment. Here, we report the utility of FTIR imaging to uncover gait changes in freely walking young (2 months of age) male rats with combined loss of Pink1 and Parkin prior to the development of gross visually apparent motor abnormality as these rats age (observed at 4-6 months), characterized by hindlimb dragging as previously reported in Pink1 knockout (KO) rats.

Identifiants

pubmed: 33522500
doi: 10.3791/62002
doi:

Substances chimiques

Ubiquitin-Protein Ligases EC 2.3.2.27
parkin protein EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Kelly L Stauch (KL)

Department of Neurological Sciences, University of Nebraska Medical Center; kelly.stauch@unmc.edu.

Steven Totusek (S)

Department of Neurological Sciences, University of Nebraska Medical Center.

Trey Farmer (T)

Department of Neurological Sciences, University of Nebraska Medical Center.

Benjamin G Lamberty (BG)

Department of Neurological Sciences, University of Nebraska Medical Center.

Kelsey N Dyball (KN)

Department of Neurological Sciences, University of Nebraska Medical Center.

Mohannad A Almikhlafi (MA)

Department of Neurological Sciences, University of Nebraska Medical Center.

Howard S Fox (HS)

Department of Neurological Sciences, University of Nebraska Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH